INTRODUCTION
BAG-1 (Bcl-2-associated athanogene 1) is a co-chaperone of hsp (heat-shock protein) 70 which executes a multitude of molecular, cellular and physiological functions. BAG-1 serves as nucleotideexchange factor of hsp70 [1] and affects the folding efficiency of this chaperone in a dose-dependent manner [2] . It has been reported to regulate growth and survival of breast cancer cells [3] and is proposed as a marker for the prediction of long-term survival in early-stage cancer [4] . In addition, BAG-1 regulates neuronal differentiation [5] and affects the differentiation and survival of haemopoietic and neuronal cells [6] . Probably related to this, BAG-1 modulates axonal and neurite outgrowth [7] . BAG-1 also plays a role in stress-related diseases such as major depression. Lithium and valproate have been shown to upregulate BAG-1 expression [8] , and mice with genetically altered levels of BAG-1 responded differently in several assays assessing stress-related behaviour [9] . Moreover, chronic mild stress led to down-regulation of BAG-1 expression, which was prevented by concomitant treatment with lithium [10] .
It is most likely that several factors contribute to this remarkable plethora of actions. First, BAG-1 is expressed in several isoforms via alternative translation initiation. These isoforms differ in size and are termed accordingly BAG-1L for the long isoform (50 kDa), BAG-1M for the middle isoform (46 kDa) and BAG-1S for the short isoform (33 kDa). These isoforms share an hsp70-interaction domain and therewith their effect on the ATPase activity of hsp70 [1, 2] . However, several studies indicate that the isoforms differ in their functions on hsp70-mediated folding and other protein actions [11, 12] .
The role of BAG-1 as co-chaperone of hsp70 might allow it to influence the many cellular functions of hsp70, which is regarded as a very general chaperone, as opposed to the more specialized chaperone hsp90 [13] . Finally, the range of effects of BAG-1 is amplified by its influence on the activity of a range of proteins that themselves have multifactorial impacts on cell signalling and physiology, for example on the protein kinase raf-1, the retinoblastoma-susceptibility protein Rb1, and steroid receptors [14] .
Among the steroid receptors, the GR (glucocorticoid receptor) is inhibited by BAG-1 in an isoform-specific manner [15, 16] , whereas the highly homologous MR (mineralocorticoid receptor) was reported to act independently of BAG-1 [15] . The function of BAG-1 as specificity determinant of corticosteroid receptor action [17] has potentially important consequences, for example for the balance of activities of the GR and MR which share the same hormone ligand. GR/MR balance plays a crucial role in cerebral stress physiology [18] and BAG-1's effect on this balance may be related to some of its neurological actions [5] [6] [7] .
Interestingly, activities of the AR (androgen receptor) and the ER (oestrogen receptor) have been reported to be stimulated by BAG-1L, but not by the shorter isoforms of BAG-1 [19] [20] [21] , with potential implications for AR-and ER-dependent malignancies [22] . The PR (progesterone receptor) appears to be the only steroid receptor for which an effect of BAG-1 has not yet been established. Homology considerations do not allow us to precisely predict the influence of BAG-1 on PR-mediated transcriptional activity. In the present study, we found PR's transcriptional activity to be inhibited by BAG-1M. In contrast with the GR, the hinge region of the PR is not required for interaction with and inhibition by BAG-1M. Surprisingly, our analyses also revealed that BAG-1M binds to the MR and inhibits MR-dependent transcription.
MATERIALS AND METHODS

Cell culture, transfection and reporter gene assays
The plasmids MTV-Luc, Gaussia-KDEL, HA-MR, HA-PR, pRK5, BAG-1M and BAG-1Mmut used for the reporter gene assay are as described previously [16, 23] . Construction of the Abbreviations used: AR, androgen receptor; BAG-1, Bcl-2-associated athanogene 1; BAG-1L, BAG-1 long isoform; BAG-1M, BAG-1 middle isoform; BAG-1S, BAG-1 short isoform; DBD, DNA-binding domain; ER, oestrogen receptor; GR, glucocorticoid receptor; HA, haemagglutinin; HEK, human embryonic kidney; hsp, heat-shock protein; MR, mineralocorticoid receptor; PR, progesterone receptor; TBS, Tris-buffered saline; WT, wild-type. 1 To whom correspondence should be addressed (email theorein@mpipsykl.mpg.de). HA-PR mutants is described in the Supplementary Online Data at http://www.BiochemJ.org/bj/441/bj4410297add.htm. Cultivation and transfection of neuroblastoma SK-N-MC (ATCC HTB-10), Cos-7 (ATCC CRL-1651) and HEK (human embryonic kidney)-293 (ATCC CRL-1573) cells were performed as described previously [24, 25] . For reporter gene assays, cells were seeded in steroid-free medium into 96-well plates 1 day before transfection, which was then performed by using ExGen Measurement of firefly luciferase and Gaussia luciferase assays was accomplished as recommended by the manufacturer (PJK) [16] . Cells were washed once with PBS (Invitrogen) and lysed in 50 μl of passive lysis buffer (0.2 % Triton X-100 and 100 mM K 2 HPO 4 /KH 2 PO 4 , pH 7.8). Firefly and Gaussia luciferase activities were measured in the same aliquot 
Co-immunoprecipitation
Co-immunoprecipitation was performed in HEK-293 cells as described previously [26, 27] , because these cells are easily amenable to efficient transfection and protein expression. Briefly, cells were seeded in steroid-free medium, harvested at approximately 90-100 % confluence and resuspended in electroporation buffer (50 mM K 2 HPO 4 , 20 mM potassium acetate, pH 7.35, and 25 mM MgSO 4 ), 400 μl per dish. Then, 2 μg of a plasmid expressing either one of the HAtagged PR WT (wild-type) or mutants or HA-tagged MR together with 8 μg of a plasmid expressing either FLAG-BAG-1M or FLAG-BAG-1-hsp70mut were added and cells were electroporated (350 V/750 μF; Gene Pulser II, Bio-Rad Laboratories). Electroporated cells were re-plated and cultured for 24 h in fresh steroid free medium. Cells either transfected with 2 μg of HA-tagged PR or non-transfected cells were used as a control for non-specific binding.
Cells were harvested in ice-cold PBS and lysed by resuspension in lysis buffer [130 mM NaCl, 20 mM Na 2 MoO 4 , 1 mM EDTA, 20 mM Tris/HCl, pH 7.5, 10 % (v/v) glycerol, and 0.5 % Triton X-100, with protease inhibitor cocktail (Sigma)]. The lysate was cleared by centrifugation at 25 000 g for 10 min at 4
• C, and the protein concentration was determined. A 0.7-1.5 mg sample of lysate was incubated overnight at 4
• C with the anti-FLAG M2-agarose affinity resin (Sigma) or with anti-HA-agarose affinity resin (Sigma) respectively. The next day, the beads were washed three times with TBS (Tris-buffered saline: 150 mM NaCl and 10 mM Tris/HCl, pH 7.0) and samples were eluted with 50 μl of 100 μg/ml FLAG-peptide solution (Sigma) or 50 μl of 100 μg/ml HA-peptide solution (Sigma) respectively in TBS and subjected to Western blot analysis. In the case of HA beads, TBS was replaced by PBS at all respective steps.
Western blot analysis
Immunoblot detection of proteins was performed largely as described in [28] . Volumes of 15-20 μl of whole-cell lysates from reporter gene assays or, in the case of co-immunoprecipitation, either 15 μg of whole protein (input) or 2.5-20 μl of eluate, were separated by SDS/PAGE and proteins were transferred on to a nitrocellulose membrane (Schleicher & Schüll) and visualized as described in [29] . The following primary antibodies were used: anti-BAG (anti-BAG-C16, Santa Cruz Biotechnology), anti-HA [HRP (horseradish peroxidase)-conjugated anti-HA, high affinity (3F10) (Roche), affinity-purified anti-FLAG (M2, Sigma), and anti-actin (I-19, Santa Cruz Biotechnology).
RESULTS
BAG-1M inhibits the PR
To assess a potential effect of BAG-1M on the PR, we employed PR-dependent reporter gene assays in Cos-7 cells in the presence or absence of co-expressed BAG-1M. We observed an inhibitory effect of BAG-1M on progesterone-mediated stimulation of PR-dependent transcription, which was more pronounced at lower than at higher hormone concentrations ( Figure 1A) . A point mutant exhibiting a grossly diminished hsp70-binding capacity [30] also exhibited a reduced potency to inhibit the PR ( Figure 1A) . We noted that the overall readings of the firefly Firefly luciferase reporter activity was normalized to the activity of the Gaussia luciferase and is represented as the fold stimulation for each cofactor condition, with the stimulation in the absence of cofactor set to 1. Since C cannot be stimulated with hormone, the ratios of firefly to Gaussia luciferase activities are compared, with the ratio in the absence of cofactor set to 1. luciferase in the reporter gene assays were somewhat lower in the case of co-expression of the hsp70-binding mutant of BAG-1M, irrespective of the presence of hormone (results not shown). Co-expression of BAG-1M did not significantly change the PR expression levels ( Figure 1B ).
BAG-1M inhibits the PR through a different mechanism from that of the GR
BAG-1M is known to inhibit the GR through binding to its hinge region [31] . To test whether homologous domains of the PR are required for BAG-1M-mediated PR inhibition, we evaluated binding of BAG-1M to the PR. We constructed a series of deletion HA-tagged PR WT and mutants were expressed in HEK-293 cells together with either FLAG-tagged BAG-1M WT ('wt') or the hsp70-interaction mutant of BAG-1M (BAG mut). The interaction between the PR and BAG-1 was assessed by co-immunoprecipitation (CoIP) using either anti-FLAG (A) or anti-HA (B)-agarose beads. In general, proteins were detected by immunoblots, except for the precipitated BAG-1M proteins and co-precipitated hsp70 in the cases of PR WT, N, C, H1 and 494-562 co-expression, which were visualized by direct Coomassie Blue staining (A). IP, immunoprecipitation.
mutants of the PR in order to map PR domains necessary for BAGmediated PR-inhibition (Figure 2 ). The design of the mutants was based on homology considerations and previously published mutants of other steroid receptors such as the AR [21] , e.g. the deletion in mutant H1 was placed in analogy to the respective deletion in the AR [21] , thus deleting the majority of the amino acids corresponding to the hinge region of the GR. Since a more extended hinge region has also been proposed, we also constructed a PR mutant with an extended deletion ( H2).
Evaluation of the transcriptional activities of the mutant PR constructs revealed hormone-independent activity of the mutant that lacks the hormone-binding domain, as expected ( C, Figure 3A) . Unexpectedly, deletion of amino acids 641-658 of the hinge region [ H1, C-terminally adjacent to the DBD (DNA-binding domain)] and deletion of amino acids 494-562 (Nterminally adjacent to the DBD) produced a PR of high activity ( Figure 3A) . Deletion of the N-terminus ( N), the DBD ( DBD) or the extended hinge region ( H2), alone or in combination ( 494-562/ H2) almost completely abolished the activity of the receptor ( Figure 3A) . We observed lowered expression of the Nterminal deletion mutant, which may contribute to its reduced transcriptional activity, whereas the other constructs showed little variation in their expression levels ( Figures 3B-3D) .
We tested the effect of BAG-1M on the transcriptionally active PR mutants in reporter gene assays using two different cell lines, SK-N-MC and Cos-7. In SK-N-MC cells, BAG-1M displayed a somewhat more pronounced effect on WT PR, but the overall pattern was similar between the two cell lines (results not shown). All PR mutants tested were susceptible to inhibition by BAG-1M (Figure 4) . The hsp70-interaction mutant of BAG-1M exhibited little or no effect on these PR mutants. Thus, since deletion of the hinge region, in contrast with the situation with the GR, did not render the PR insensitive to BAG-1M, the PR probably interacts via other domains with BAG-1M than those of the GR.
To map the interaction of BAG-1M with the PR, we performed immunoprecipitation experiments. BAG-1M or its hsp70-binding mutant were each co-expressed with one of the PR constructs in HEK-293 cells. In one set of experiments, BAG-1M or the hsp70-binding mutant were precipitated, and the amounts of coprecipitated PR variants were assessed ( Figure 5A ). In another set of experiments, we precipitated the diverse PR mutants and determined the amount of co-precipitated BAG-1M WT and mutant protein ( Figure 5B) . Results from both sets of experiments indicated that BAG-1M binds to all deletion mutants of the PR, except for the DBD ( Figure 5 and results not shown) . Moreover, BAG-1M binding to the PR was hsp70-dependent, because the
Figure 6 BAG-1M binds to and inhibits the MR
(A) HA-tagged MR and either FLAG-tagged BAG-1M WT (BAGIMwt) or the hsp70-interaction mutant of BAG-1M (BAG1mut) were co-expressed in HEK-293 cells, and the interaction was assessed by co-immunoprecipitation (CoIP) using anti-FLAG-agarose beads. The MR and hsc70 (heat-shock cognate 70) levels were determined by Western blotting, and the precipitated BAG-1 proteins were assessed by Coomassie Blue staining of acrylamide gels. IP, immunoprecipitation. (B) Cos-7 cells were transfected with reporter, control, MR and either BAG-1M-or BAG-1Mmut-expressing plasmids and stimulated with cortisol as indicated. Firefly luciferase reporter activity was normalized to the activity of the Gaussia luciferase and is presented as the fold stimulation over the control without hormone. (C) Cos-7 cells were transfected with reporter, control, MR and one of the BAG-1-expressing plasmids (C, empty expression vector; M, BAG-1M; S, BAG-1S; L, BAG-1L) and stimulated with 10 nM aldosterone. Firefly luciferase reporter activity was normalized to the activity of the Gaussia luciferase and results are presented in relation to the fold stimulation in the absence of co-transfected BAG-1 (C).
point mutant with reduced hsp70 interaction showed significantly less interaction with the PR and its deletion mutants. We also confirmed hsp90 binding to the hormone-binding domain of the PR ( Figure 5B ).
BAG-1M inhibits the transcriptional activity of the MR
In the course of the interaction analyses of the PR and BAG presented in Figure 5 , we also included the MR, originally with the intention to use it as a control [17] . Surprisingly, we observed a robust interaction of BAG-1M with the MR, which was largely hsp70-dependent ( Figure 6A ). Moreover, BAG-1M, but not its hsp70-interaction mutant, inhibited MR's transcriptional activity in reporter gene assays ( Figure 6B ). As with the GR, BAG-1 inhibits the MR in an isoform-specific manner, i.e. BAG-1M and BAG-1L act on the MR, whereas BAG-1S does not ( Figure 6C ). The same isoform specificity was observed for the PR (results not shown).
DISCUSSION
The effects of BAG-1M on the MR and PR reported in the present paper establish that the activities of all five steroid receptors, i.e. GR, MR, PR, AR and ER, are influenced by BAG-1, albeit in different directions and with various BAG-1 isoform specificities. The GR [15, 16] , MR and PR are inhibited by BAG-1M and BAG-1L, whereas the AR and ER are stimulated by BAG-1L [19] [20] [21] . BAG-1M interacts with the GR via the hinge region of the receptor [15] , whereas the interaction of BAG-1L with the AR occurs through both the N-and the C-terminal regions [19, 21] . The domain requirement of the ER for the interaction with BAG-1L [20] has not yet been mapped. We found that virtually all regions of the PR contribute to binding to BAG-1M. Our analyses revealed only the DBD not to bind BAG-1M, probably because this domain is also not binding to hsp70. The addition of short stretches of 40-70 amino acids N-terminally or C-terminally to the DBD restored hsp70 and BAG-1M binding. As in the case of the GR, and largely also the AR, BAG-1M needs hsp70 for its interaction with the PR. These different binding requirements are probably due to the distribution of hsp70-binding sites within the receptors. The hsp70-binding site might depend on the primary sequences of the receptors and also their populations of partially folded states. Thus it is likely that BAG-1M modulates the actions of hsp70 on steroid receptors. In addition, it is possible that folding intermediates differ between steroid receptors and might be the basis for the differences in the domain requirement for the BAG-1 interaction.
Steroid receptors are important regulators of a multitude of cellular and physiological functions [32] . They are regulated, in turn, by a variety of nuclear and cytosolic cofactors [33] , which can be reasonably assumed to contribute to the complexity of steroid receptor action. Molecular chaperones and co-chaperones such as BAG-1 are among the major determinants of steroid receptor function [14] , and it is plausible that this link provides an explanation for some of the numerous cellular functions of BAG-1, and possibly other chaperones as well.
For example, several studies reported anti-apoptotic actions of BAG-1 in different cell types [34] , and BAG-1 was subsequently described as a marker for the malignancy of various cancer types [3, 4, 35] . Potential mechanisms for the cell-survival effects of BAG-1 include enhancement of Raf-1-mediated signalling [36, 37] and actions via the well-described anti-apoptotic protein Bcl-2 [38] . In addition, the modulatory effects of BAG-1M on the activity of steroid receptors could also contribute to cell proliferation, particularly in hormone-dependent breast cancer or prostate cancer [3, 4] .
Imbalanced activity of the ER and PR is considered to be the most important determinant in the development of endometrial cancer. Activated ERs drive proliferation of endometrial glandular epithelium through various mechanisms, whereas activated PR opposes the proliferative actions of the ER [39] . Thus BAG-1 changes the balance of ER and PR activities in two ways towards higher cell proliferation: (i) by the inhibitory effect of BAG-1M on the PR as reported in the present paper; and (ii) by the stimulatory impact of BAG-1L on the ER [20] . BAG-1 is indeed expressed in normal and neoplastic endometrium, with high-grade cancer specimens displaying the highest expression [40] . A later study also found higher expression of BAG-1 in endometrial cancer than in normal endometrium; the extent of expression level difference correlates with the grade of malignancy [41] .
Whereas the effect of BAG-1M on the transcriptional activity of the MR described in the present paper could, in principle, link BAG-1 to all actions of the MR, we confine the discussion to potential consequences in the brain, because a role of BAG-1 for several functions in the brain has been reported. Since a balanced activation of both the MR and GR is important to maintain brain physiology [18, 42] , and given our observation of BAG-1M's ability to affect both receptors, it will not be easy to pinpoint the contribution of BAG-1 to the physiological function of these receptors. Nevertheless, it is interesting to parallel findings of MR physiology with those of BAG-1 physiology. The MR exerts a protective effect on GR-induced apoptosis in hippocampal neurons [43] . This is consistent with the concept that the balance between the GR and MR controls neuron fate in the limbic system [18] and in line with the degeneration of hippocampal granule cells and impaired neurogenesis observed with the MR-knockout mice [44] . BAG-1 has been reported as a regulator and marker of neuronal differentiation and as a potent neuroprotectant [5, 45] . The effects of the MR and GR regulator BAG-1 on neurite and axonal outgrowth [7] may also pertain to the complex effects of excess or insufficient corticosterone exposure to dendritic morphology in mice [46] . Finally, genetically engineered mice with altered expression of the GR, the MR or BAG-1 have been proposed to serve as models for depression-and anxiety-like behaviour [9, 47, 48] .
In summary, our observations on the inhibitory function of BAG-1M on the activity of the PR and MR contribute important novel molecular actions of this hsp70 cofactor, which is considered to be a potential target in the treatment of several diseases.
AUTHOR CONTRIBUTION
Regina Knapp performed cloning, co-immunoprecipitations and reporter gene assays. Andrea Steiner contributed the reporter gene assay in Figure 6 (B). Ulrike Schmidt contributed the reporter gene assay in Figure 6 (C). Kathrin Hafner assisted with reporter gene assays and co-immunoprecipitations. Theo Rein designed the study and wrote the paper with important contributions from Regina Knapp, Florian Holsboer and Ulrike Schmidt.
